Loading…

Bioactive indanes: insight into the bioactivity of indane dimers related to the lead anti‐inflammatory molecule PH46A

Objectives PH46A (1) demonstrates significant anti‐inflammatory activity in phenotypic models but its mechanism and site of action have been elusive. Current study focused on the bioactivity of PH46 (2) and related novel indane dimers (6‐10) to investigate the impact of changes in substitution and s...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmacy and pharmacology 2020-07, Vol.72 (7), p.927-937
Main Authors: Chan, Kit, Frankish, Neil, Zhang, Tao, Ece, Abdulilah, Cannon, Aoife, O'Sullivan, Jacintha, Sheridan, Helen
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4489-6a268d45f48a23fb2c7746fbab364c69c89b5b61f60480df0aa84af701ca46573
cites cdi_FETCH-LOGICAL-c4489-6a268d45f48a23fb2c7746fbab364c69c89b5b61f60480df0aa84af701ca46573
container_end_page 937
container_issue 7
container_start_page 927
container_title Journal of pharmacy and pharmacology
container_volume 72
creator Chan, Kit
Frankish, Neil
Zhang, Tao
Ece, Abdulilah
Cannon, Aoife
O'Sullivan, Jacintha
Sheridan, Helen
description Objectives PH46A (1) demonstrates significant anti‐inflammatory activity in phenotypic models but its mechanism and site of action have been elusive. Current study focused on the bioactivity of PH46 (2) and related novel indane dimers (6‐10) to investigate the impact of changes in substitution and stereochemistry at the C‐1 and C‐2 positions of the PH46 (2) scaffold. Methods Cytotoxicity profiles of compounds were established using THP‐1 macrophages and SW480 cells. Effects of the compounds were then evaluated at 10 µm using 5‐lipoxygenase (LOX) and 15‐LOX enzymes, and 5‐LOX binding was evaluated in silico against NDGA, nitric oxide (NO) released from LPS‐induced SW480 cells and cytokines in THP‐1 macrophages (IL‐6, IL‐1β, TNF‐α and IFN‐γ) and in SW480 cells (IL‐8). Key findings PH46 (2) and 7 cause reduction in NO, inhibition of 5‐LOX with high binding energy and no cytotoxicity effects in THP‐1 macrophages and SW480 cell lines (up to 50 µm). The cytokine profiling of the series demonstrated inhibition of IL‐6 and TNF‐α in THP‐1 macrophages together with IL‐8 in SW480 cells. Conclusions The observed profile of cytokine modulation (IL‐6/ TNF‐α, IL‐8) and inhibition of release of NO and 5‐LOX may contribute to the in vivo effects demonstrated by indane dimers and PH46A (1) in murine models of colitis.
doi_str_mv 10.1111/jphp.13269
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7497186</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2410524028</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4489-6a268d45f48a23fb2c7746fbab364c69c89b5b61f60480df0aa84af701ca46573</originalsourceid><addsrcrecordid>eNp9kcFO3DAQhi1UBFvaSx-gstRbpYDtOI7TQyVApQtCYg_t2Zo4NutVEm9tL2hvfYQ-Y58E0w2oXPBlLM2nb2b0I_SBkmOa38lqvVwf05KJZg_NGOGsqGkl36AZIYwVZVWXh-htjCtCSC2EOECHJSsJpYzM0P2Z86CTuzPYjR2MJn7Jn-hulynX5HFaGtxOjEtb7O0E4s4NJkQcTA_JdHhiewMdhjG5v7__uNH2MAyQfNjiwfdGb3qDF3MuTt-hfQt9NO-neoR-Xnz7cT4vrm--X56fXheac9kUApiQHa8sl8BK2zJd11zYFtpScC0aLZu2agW1gnBJOksAJAdbE6qBi3z5Efq686437WA6bcYUoFfr4AYIW-XBqZed0S3Vrb9TNW9qKkUWfJoEwf_amJjUym_CmHdWjFNSMU6YzNTnHaWDjzEY-zyBEvUYknoMSf0LKcMf_9_pGX1KJQN0B9y73mxfUamrxXyxkz4AiZWftg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2410524028</pqid></control><display><type>article</type><title>Bioactive indanes: insight into the bioactivity of indane dimers related to the lead anti‐inflammatory molecule PH46A</title><source>Oxford Journals Online</source><creator>Chan, Kit ; Frankish, Neil ; Zhang, Tao ; Ece, Abdulilah ; Cannon, Aoife ; O'Sullivan, Jacintha ; Sheridan, Helen</creator><creatorcontrib>Chan, Kit ; Frankish, Neil ; Zhang, Tao ; Ece, Abdulilah ; Cannon, Aoife ; O'Sullivan, Jacintha ; Sheridan, Helen</creatorcontrib><description>Objectives PH46A (1) demonstrates significant anti‐inflammatory activity in phenotypic models but its mechanism and site of action have been elusive. Current study focused on the bioactivity of PH46 (2) and related novel indane dimers (6‐10) to investigate the impact of changes in substitution and stereochemistry at the C‐1 and C‐2 positions of the PH46 (2) scaffold. Methods Cytotoxicity profiles of compounds were established using THP‐1 macrophages and SW480 cells. Effects of the compounds were then evaluated at 10 µm using 5‐lipoxygenase (LOX) and 15‐LOX enzymes, and 5‐LOX binding was evaluated in silico against NDGA, nitric oxide (NO) released from LPS‐induced SW480 cells and cytokines in THP‐1 macrophages (IL‐6, IL‐1β, TNF‐α and IFN‐γ) and in SW480 cells (IL‐8). Key findings PH46 (2) and 7 cause reduction in NO, inhibition of 5‐LOX with high binding energy and no cytotoxicity effects in THP‐1 macrophages and SW480 cell lines (up to 50 µm). The cytokine profiling of the series demonstrated inhibition of IL‐6 and TNF‐α in THP‐1 macrophages together with IL‐8 in SW480 cells. Conclusions The observed profile of cytokine modulation (IL‐6/ TNF‐α, IL‐8) and inhibition of release of NO and 5‐LOX may contribute to the in vivo effects demonstrated by indane dimers and PH46A (1) in murine models of colitis.</description><identifier>ISSN: 0022-3573</identifier><identifier>EISSN: 2042-7158</identifier><identifier>DOI: 10.1111/jphp.13269</identifier><identifier>PMID: 32301120</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Animal models ; Animals ; Anti-Inflammatory Agents - immunology ; Anti-Inflammatory Agents - pharmacology ; Biological activity ; Biological Availability ; Cell Line, Tumor - drug effects ; Cell lines ; Colitis ; cytokine profiling ; Cytokines ; Cytokines - immunology ; Cytotoxicity ; Drug Design ; Humans ; indanes ; Indans - chemistry ; Indans - immunology ; Indans - pharmacology ; Inflammation ; inflammatory bowel disease ; Inflammatory Bowel Diseases - drug therapy ; Inflammatory Bowel Diseases - immunology ; Interferon ; Lipopolysaccharides ; Lipoxygenase ; Macrophages ; Mice ; Molecular Structure ; Nitric oxide ; Research Paper ; Stereochemistry ; Structure-Activity Relationship ; THP-1 Cells - drug effects ; Tumor necrosis factor</subject><ispartof>Journal of pharmacy and pharmacology, 2020-07, Vol.72 (7), p.927-937</ispartof><rights>2020 Royal Pharmaceutical Society</rights><rights>2020 Royal Pharmaceutical Society.</rights><rights>2020. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 The Authors. Journal of Pharmacy and Pharmacology published by John Wiley &amp; Sons Ltd on behalf of Royal Pharmaceutical Society 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4489-6a268d45f48a23fb2c7746fbab364c69c89b5b61f60480df0aa84af701ca46573</citedby><cites>FETCH-LOGICAL-c4489-6a268d45f48a23fb2c7746fbab364c69c89b5b61f60480df0aa84af701ca46573</cites><orcidid>0000-0002-9825-7263 ; 0000-0001-8622-9858 ; 0000-0002-7739-5528 ; 0000-0001-5040-9371 ; 0000-0002-9454-752X ; 0000-0002-3087-5145 ; 0000-0003-1079-5364</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32301120$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chan, Kit</creatorcontrib><creatorcontrib>Frankish, Neil</creatorcontrib><creatorcontrib>Zhang, Tao</creatorcontrib><creatorcontrib>Ece, Abdulilah</creatorcontrib><creatorcontrib>Cannon, Aoife</creatorcontrib><creatorcontrib>O'Sullivan, Jacintha</creatorcontrib><creatorcontrib>Sheridan, Helen</creatorcontrib><title>Bioactive indanes: insight into the bioactivity of indane dimers related to the lead anti‐inflammatory molecule PH46A</title><title>Journal of pharmacy and pharmacology</title><addtitle>J Pharm Pharmacol</addtitle><description>Objectives PH46A (1) demonstrates significant anti‐inflammatory activity in phenotypic models but its mechanism and site of action have been elusive. Current study focused on the bioactivity of PH46 (2) and related novel indane dimers (6‐10) to investigate the impact of changes in substitution and stereochemistry at the C‐1 and C‐2 positions of the PH46 (2) scaffold. Methods Cytotoxicity profiles of compounds were established using THP‐1 macrophages and SW480 cells. Effects of the compounds were then evaluated at 10 µm using 5‐lipoxygenase (LOX) and 15‐LOX enzymes, and 5‐LOX binding was evaluated in silico against NDGA, nitric oxide (NO) released from LPS‐induced SW480 cells and cytokines in THP‐1 macrophages (IL‐6, IL‐1β, TNF‐α and IFN‐γ) and in SW480 cells (IL‐8). Key findings PH46 (2) and 7 cause reduction in NO, inhibition of 5‐LOX with high binding energy and no cytotoxicity effects in THP‐1 macrophages and SW480 cell lines (up to 50 µm). The cytokine profiling of the series demonstrated inhibition of IL‐6 and TNF‐α in THP‐1 macrophages together with IL‐8 in SW480 cells. Conclusions The observed profile of cytokine modulation (IL‐6/ TNF‐α, IL‐8) and inhibition of release of NO and 5‐LOX may contribute to the in vivo effects demonstrated by indane dimers and PH46A (1) in murine models of colitis.</description><subject>Animal models</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents - immunology</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Biological activity</subject><subject>Biological Availability</subject><subject>Cell Line, Tumor - drug effects</subject><subject>Cell lines</subject><subject>Colitis</subject><subject>cytokine profiling</subject><subject>Cytokines</subject><subject>Cytokines - immunology</subject><subject>Cytotoxicity</subject><subject>Drug Design</subject><subject>Humans</subject><subject>indanes</subject><subject>Indans - chemistry</subject><subject>Indans - immunology</subject><subject>Indans - pharmacology</subject><subject>Inflammation</subject><subject>inflammatory bowel disease</subject><subject>Inflammatory Bowel Diseases - drug therapy</subject><subject>Inflammatory Bowel Diseases - immunology</subject><subject>Interferon</subject><subject>Lipopolysaccharides</subject><subject>Lipoxygenase</subject><subject>Macrophages</subject><subject>Mice</subject><subject>Molecular Structure</subject><subject>Nitric oxide</subject><subject>Research Paper</subject><subject>Stereochemistry</subject><subject>Structure-Activity Relationship</subject><subject>THP-1 Cells - drug effects</subject><subject>Tumor necrosis factor</subject><issn>0022-3573</issn><issn>2042-7158</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kcFO3DAQhi1UBFvaSx-gstRbpYDtOI7TQyVApQtCYg_t2Zo4NutVEm9tL2hvfYQ-Y58E0w2oXPBlLM2nb2b0I_SBkmOa38lqvVwf05KJZg_NGOGsqGkl36AZIYwVZVWXh-htjCtCSC2EOECHJSsJpYzM0P2Z86CTuzPYjR2MJn7Jn-hulynX5HFaGtxOjEtb7O0E4s4NJkQcTA_JdHhiewMdhjG5v7__uNH2MAyQfNjiwfdGb3qDF3MuTt-hfQt9NO-neoR-Xnz7cT4vrm--X56fXheac9kUApiQHa8sl8BK2zJd11zYFtpScC0aLZu2agW1gnBJOksAJAdbE6qBi3z5Efq686437WA6bcYUoFfr4AYIW-XBqZed0S3Vrb9TNW9qKkUWfJoEwf_amJjUym_CmHdWjFNSMU6YzNTnHaWDjzEY-zyBEvUYknoMSf0LKcMf_9_pGX1KJQN0B9y73mxfUamrxXyxkz4AiZWftg</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Chan, Kit</creator><creator>Frankish, Neil</creator><creator>Zhang, Tao</creator><creator>Ece, Abdulilah</creator><creator>Cannon, Aoife</creator><creator>O'Sullivan, Jacintha</creator><creator>Sheridan, Helen</creator><general>Wiley Subscription Services, Inc</general><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9825-7263</orcidid><orcidid>https://orcid.org/0000-0001-8622-9858</orcidid><orcidid>https://orcid.org/0000-0002-7739-5528</orcidid><orcidid>https://orcid.org/0000-0001-5040-9371</orcidid><orcidid>https://orcid.org/0000-0002-9454-752X</orcidid><orcidid>https://orcid.org/0000-0002-3087-5145</orcidid><orcidid>https://orcid.org/0000-0003-1079-5364</orcidid></search><sort><creationdate>202007</creationdate><title>Bioactive indanes: insight into the bioactivity of indane dimers related to the lead anti‐inflammatory molecule PH46A</title><author>Chan, Kit ; Frankish, Neil ; Zhang, Tao ; Ece, Abdulilah ; Cannon, Aoife ; O'Sullivan, Jacintha ; Sheridan, Helen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4489-6a268d45f48a23fb2c7746fbab364c69c89b5b61f60480df0aa84af701ca46573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animal models</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents - immunology</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Biological activity</topic><topic>Biological Availability</topic><topic>Cell Line, Tumor - drug effects</topic><topic>Cell lines</topic><topic>Colitis</topic><topic>cytokine profiling</topic><topic>Cytokines</topic><topic>Cytokines - immunology</topic><topic>Cytotoxicity</topic><topic>Drug Design</topic><topic>Humans</topic><topic>indanes</topic><topic>Indans - chemistry</topic><topic>Indans - immunology</topic><topic>Indans - pharmacology</topic><topic>Inflammation</topic><topic>inflammatory bowel disease</topic><topic>Inflammatory Bowel Diseases - drug therapy</topic><topic>Inflammatory Bowel Diseases - immunology</topic><topic>Interferon</topic><topic>Lipopolysaccharides</topic><topic>Lipoxygenase</topic><topic>Macrophages</topic><topic>Mice</topic><topic>Molecular Structure</topic><topic>Nitric oxide</topic><topic>Research Paper</topic><topic>Stereochemistry</topic><topic>Structure-Activity Relationship</topic><topic>THP-1 Cells - drug effects</topic><topic>Tumor necrosis factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chan, Kit</creatorcontrib><creatorcontrib>Frankish, Neil</creatorcontrib><creatorcontrib>Zhang, Tao</creatorcontrib><creatorcontrib>Ece, Abdulilah</creatorcontrib><creatorcontrib>Cannon, Aoife</creatorcontrib><creatorcontrib>O'Sullivan, Jacintha</creatorcontrib><creatorcontrib>Sheridan, Helen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of pharmacy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chan, Kit</au><au>Frankish, Neil</au><au>Zhang, Tao</au><au>Ece, Abdulilah</au><au>Cannon, Aoife</au><au>O'Sullivan, Jacintha</au><au>Sheridan, Helen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bioactive indanes: insight into the bioactivity of indane dimers related to the lead anti‐inflammatory molecule PH46A</atitle><jtitle>Journal of pharmacy and pharmacology</jtitle><addtitle>J Pharm Pharmacol</addtitle><date>2020-07</date><risdate>2020</risdate><volume>72</volume><issue>7</issue><spage>927</spage><epage>937</epage><pages>927-937</pages><issn>0022-3573</issn><eissn>2042-7158</eissn><abstract>Objectives PH46A (1) demonstrates significant anti‐inflammatory activity in phenotypic models but its mechanism and site of action have been elusive. Current study focused on the bioactivity of PH46 (2) and related novel indane dimers (6‐10) to investigate the impact of changes in substitution and stereochemistry at the C‐1 and C‐2 positions of the PH46 (2) scaffold. Methods Cytotoxicity profiles of compounds were established using THP‐1 macrophages and SW480 cells. Effects of the compounds were then evaluated at 10 µm using 5‐lipoxygenase (LOX) and 15‐LOX enzymes, and 5‐LOX binding was evaluated in silico against NDGA, nitric oxide (NO) released from LPS‐induced SW480 cells and cytokines in THP‐1 macrophages (IL‐6, IL‐1β, TNF‐α and IFN‐γ) and in SW480 cells (IL‐8). Key findings PH46 (2) and 7 cause reduction in NO, inhibition of 5‐LOX with high binding energy and no cytotoxicity effects in THP‐1 macrophages and SW480 cell lines (up to 50 µm). The cytokine profiling of the series demonstrated inhibition of IL‐6 and TNF‐α in THP‐1 macrophages together with IL‐8 in SW480 cells. Conclusions The observed profile of cytokine modulation (IL‐6/ TNF‐α, IL‐8) and inhibition of release of NO and 5‐LOX may contribute to the in vivo effects demonstrated by indane dimers and PH46A (1) in murine models of colitis.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32301120</pmid><doi>10.1111/jphp.13269</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-9825-7263</orcidid><orcidid>https://orcid.org/0000-0001-8622-9858</orcidid><orcidid>https://orcid.org/0000-0002-7739-5528</orcidid><orcidid>https://orcid.org/0000-0001-5040-9371</orcidid><orcidid>https://orcid.org/0000-0002-9454-752X</orcidid><orcidid>https://orcid.org/0000-0002-3087-5145</orcidid><orcidid>https://orcid.org/0000-0003-1079-5364</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3573
ispartof Journal of pharmacy and pharmacology, 2020-07, Vol.72 (7), p.927-937
issn 0022-3573
2042-7158
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7497186
source Oxford Journals Online
subjects Animal models
Animals
Anti-Inflammatory Agents - immunology
Anti-Inflammatory Agents - pharmacology
Biological activity
Biological Availability
Cell Line, Tumor - drug effects
Cell lines
Colitis
cytokine profiling
Cytokines
Cytokines - immunology
Cytotoxicity
Drug Design
Humans
indanes
Indans - chemistry
Indans - immunology
Indans - pharmacology
Inflammation
inflammatory bowel disease
Inflammatory Bowel Diseases - drug therapy
Inflammatory Bowel Diseases - immunology
Interferon
Lipopolysaccharides
Lipoxygenase
Macrophages
Mice
Molecular Structure
Nitric oxide
Research Paper
Stereochemistry
Structure-Activity Relationship
THP-1 Cells - drug effects
Tumor necrosis factor
title Bioactive indanes: insight into the bioactivity of indane dimers related to the lead anti‐inflammatory molecule PH46A
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T01%3A22%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bioactive%20indanes:%20insight%20into%20the%20bioactivity%20of%20indane%20dimers%20related%20to%20the%20lead%20anti%E2%80%90inflammatory%20molecule%20PH46A&rft.jtitle=Journal%20of%20pharmacy%20and%20pharmacology&rft.au=Chan,%20Kit&rft.date=2020-07&rft.volume=72&rft.issue=7&rft.spage=927&rft.epage=937&rft.pages=927-937&rft.issn=0022-3573&rft.eissn=2042-7158&rft_id=info:doi/10.1111/jphp.13269&rft_dat=%3Cproquest_pubme%3E2410524028%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4489-6a268d45f48a23fb2c7746fbab364c69c89b5b61f60480df0aa84af701ca46573%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2410524028&rft_id=info:pmid/32301120&rfr_iscdi=true